· Periodic Report
Q3 revenue KRW 10.2 billion, loss of KRW 2.8 billion from the main business
Samsung Pharm sold KRW 10.2 billion in Q3 and lost KRW 2.8 billion from its main business; sales fell 14.9% from a year earlier and rose 3.1% from the prior quarter.